Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Dec;19(12):821-822.
doi: 10.1038/d41573-020-00146-5.

Informing single-arm clinical trials with external controls

Ruthie Davi, Nirosha Mahendraratnam, Arnaub Chatterjee, C Jill Dawson, Rachel Sherman

Informing single-arm clinical trials with external controls

Ruthie Davi et al. Nat Rev Drug Discov. 2020 Dec.
No abstract available

PubMed Disclaimer

References

    1. Grayling, M. J., Dimairo, M., Mander, A. P., Jaki, T. F. A review of perspectives on the use of randomization in phase II oncology trials. J. Natl Cancer Inst. 111, 1255–1262 (2019). - PubMed - DOI - PMC
    1. Austin, P. C. An introduction to propensity score methods for reducing the effects of confounding in observational studies. Multivariate Behav. Res. 46, 399–424 (2011). - PubMed - DOI - PMC
    1. Gokbuget, N. et al. Blinatumomab vs historical standard therapy of adult relapsed/refractory acute lymphoblastic leukemia. Blood Cancer J. 6, e473 (2016). - PubMed - DOI - PMC
    1. Cave, A., Kurz, X. & Arlett, P. Real-world data for regulatory decision making: challenges and possible solutions for Europe. Clin. Pharmacol. Ther. 106, 36–39 (2019). - PubMed - DOI - PMC
    1. Sherman, R. E. et al. Accelerating development of scientific evidence for medical products within the existing US regulatory framework. Nat. Rev. Drug Discov. 16, 297–298 (2017). - PubMed - DOI

LinkOut - more resources